These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 35247197)
1. Distinct power of bone marrow microRNA signatures and tumor suppressor genes for early detection of acute leukemia. Memari F; Tavakolpour V; Mohajeri N; Poopak B; Fallah P; Alizadeh E; Kouhkan F; Zarghami N Clin Transl Oncol; 2022 Jul; 24(7):1372-1380. PubMed ID: 35247197 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Mi S; Lu J; Sun M; Li Z; Zhang H; Neilly MB; Wang Y; Qian Z; Jin J; Zhang Y; Bohlander SK; Le Beau MM; Larson RA; Golub TR; Rowley JD; Chen J Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19971-6. PubMed ID: 18056805 [TBL] [Abstract][Full Text] [Related]
3. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. Wang Y; Li Z; He C; Wang D; Yuan X; Chen J; Jin J Blood Cells Mol Dis; 2010 Mar; 44(3):191-7. PubMed ID: 20110180 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia. Zhang P; Sun D; Sun X; Li H Eur J Med Res; 2020 Sep; 25(1):42. PubMed ID: 32938467 [TBL] [Abstract][Full Text] [Related]
5. Identification of Acute Myeloid Leukemia Bone Marrow Circulating MicroRNAs. Moussa Agha D; Rouas R; Najar M; Bouhtit F; Naamane N; Fayyad-Kazan H; Bron D; Meuleman N; Lewalle P; Merimi M Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992819 [TBL] [Abstract][Full Text] [Related]
6. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia. Lin X; Wang Z; Wang Y; Feng W Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789 [TBL] [Abstract][Full Text] [Related]
7. microRNA-106b-5p and Rab10: Potential Markers of Acute Myeloid Leukemia. Xu L; Wang A; Guan H Cancer Biother Radiopharm; 2024 Sep; 39(7):492-501. PubMed ID: 38949985 [TBL] [Abstract][Full Text] [Related]
8. The pathological role and prognostic impact of miR-181 in acute myeloid leukemia. Weng H; Lal K; Yang FF; Chen J Cancer Genet; 2015 May; 208(5):225-9. PubMed ID: 25686674 [TBL] [Abstract][Full Text] [Related]
9. miR-370 is better than miR-375 as a non-invasive diagnostic biomarker for pediatric acute myeloid leukemia patients. Ali MM; Mohamed RH; Sayed AA; Ahmed S; Yassin DA; El-Sayed WM Cancer Biomark; 2022; 34(3):403-411. PubMed ID: 35094987 [TBL] [Abstract][Full Text] [Related]
10. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia. Zhang R; Yang JY; Sun HQ; Jia H; Liao J; Shi YJ; Li G Eur Rev Med Pharmacol Sci; 2015; 19(14):2679-88. PubMed ID: 26221900 [TBL] [Abstract][Full Text] [Related]
11. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia. Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147 [TBL] [Abstract][Full Text] [Related]
13. Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. Fayyad-Kazan H; Bitar N; Najar M; Lewalle P; Fayyad-Kazan M; Badran R; Hamade E; Daher A; Hussein N; ElDirani R; Berri F; Vanhamme L; Burny A; Martiat P; Rouas R; Badran B J Transl Med; 2013 Feb; 11():31. PubMed ID: 23391324 [TBL] [Abstract][Full Text] [Related]
14. Use of extracellular vesicle microRNA profiles in patients with acute myeloid leukemia for the identification of novel biomarkers. Kang KW; Gim JA; Hong S; Kim HK; Choi Y; Park JH; Park Y PLoS One; 2024; 19(8):e0306962. PubMed ID: 39178208 [TBL] [Abstract][Full Text] [Related]
15. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia. Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705 [TBL] [Abstract][Full Text] [Related]
16. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia. Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic relevance of serum miR-195 in pediatric acute myeloid leukemia. Hong Z; Zhang R; Qi H Cancer Biomark; 2018 Feb; 21(2):269-275. PubMed ID: 29226854 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of microRNA-143 inhibits growth and induces apoptosis in human leukemia cells. Shen JZ; Zhang YY; Fu HY; Wu DS; Zhou HR Oncol Rep; 2014 May; 31(5):2035-42. PubMed ID: 24626955 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-206 serves as a tumor suppressor in pediatric acute myeloid leukemia by targeting Cyclin D1. Liu H; Wu H; Qin X Pathol Res Pract; 2019 Oct; 215(10):152554. PubMed ID: 31431298 [TBL] [Abstract][Full Text] [Related]
20. miR-582-5p serves as an antioncogenic biomarker in intermediate risk AML with normal cytogenetics and could inhibit proliferation and induce apoptosis of leukemia cells. Wang X; Feng Y; Zhang P; Chen H; Bai J; Wang F; He A Cell Biol Int; 2020 Oct; 44(10):2021-2030. PubMed ID: 32543749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]